VKTX Insider Trading

Insider Ownership Percentage: 4.40%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $24,327,721.43

Viking Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Viking Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Viking Therapeutics Share Price & Price History

Current Price: $81.87
Price Change: Price Decrease of -1.47 (-1.76%)
As of 03/28/2024 03:41 PM ET

This chart shows the closing price history over time for VKTX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Viking Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/8/2024Brian LianCEOSell269,079$26.87$7,230,152.732,184,882View SEC Filing Icon  
2/8/2024Sarah Kathryn RouanDirectorSell25,000$28.05$701,250.00View SEC Filing Icon  
1/30/2024Brian LianCEOSell35,000$23.95$838,250.002,264,882View SEC Filing Icon  
1/19/2024Sarah Kathryn RouanDirectorSell30,000$23.05$691,500.00View SEC Filing Icon  
1/4/2024Greg ZanteCFOSell15,000$17.90$268,500.00180,730View SEC Filing Icon  
5/16/2023Charles A Rowland JrDirectorSell40,000$25.00$1,000,000.0030,000View SEC Filing Icon  
5/1/2023Brian LianCEOSell45,000$22.45$1,010,250.002,197,963View SEC Filing Icon  
4/24/2023Lawson MacartneyDirectorSell16,000$22.00$352,000.0047,965View SEC Filing Icon  
4/19/2023Brian LianCEOSell35,000$21.45$750,750.002,242,963View SEC Filing Icon  
4/17/2023Brian LianCEOSell155,000$20.45$3,169,750.002,277,963View SEC Filing Icon  
4/17/2023Greg ZanteCFOSell7,500$20.00$150,000.00149,279View SEC Filing Icon  
4/17/2023Lawson MacartneyDirectorSell20,786$20.00$415,720.0047,965View SEC Filing Icon  
4/17/2023Marianna ManciniCOOSell12,500$20.00$250,000.00287,763View SEC Filing Icon  
4/13/2023Brian LianCEOSell79,336$18.45$1,463,749.202,307,963View SEC Filing Icon  
4/11/2023Greg ZanteCFOSell56,295$18.00$1,013,310.00149,279View SEC Filing Icon  
4/3/2023Brian LianCEOSell22,000$17.85$392,700.002,232,963View SEC Filing Icon  
4/3/2023Greg ZanteCFOSell30,911$18.00$556,398.00147,778View SEC Filing Icon  
3/31/2023Brian LianCEOSell67,970$17.45$1,186,076.502,254,963View SEC Filing Icon  
3/30/2023Greg ZanteCFOSell131,029$17.00$2,227,493.00147,778View SEC Filing Icon  
3/29/2023Marianna ManciniCOOSell41,242$16.00$659,872.00261,895View SEC Filing Icon  
6/10/2021Matthew W. FoehrDirectorBuy20,000$5.69$113,800.0066,250View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Viking Therapeutics (NASDAQ:VKTX)

76.03% of Viking Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at VKTX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Viking Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/11/2024Vanguard Group Inc.5,381,904$100.16M0.0%+1.8%5.356%Search for SEC Filing on Google Icon
3/1/2024Goldman Sachs Group Inc.1,119,885$20.84M0.0%+88.3%1.114%Search for SEC Filing on Google Icon
2/28/2024American International Group Inc.47,794$0.89M0.0%-0.4%0.048%Search for SEC Filing on Google Icon
2/26/2024Virtu Financial LLC29,394$0.55M0.0%+15.1%0.029%Search for SEC Filing on Google Icon
2/16/2024Price T Rowe Associates Inc. MD55,236$1.03M0.0%+33.3%0.055%Search for SEC Filing on Google Icon
2/16/2024GSA Capital Partners LLP68,415$1.27M0.1%-23.8%0.068%Search for SEC Filing on Google Icon
2/15/2024Chartwell Investment Partners LLC54,469$1.01M0.0%-11.9%0.054%Search for SEC Filing on Google Icon
2/15/2024Virtus ETF Advisers LLC4,817$90K0.1%+9.0%0.005%Search for SEC Filing on Google Icon
2/15/2024Legal & General Group Plc95,506$1.78M0.0%+1.0%0.095%Search for SEC Filing on Google Icon
2/15/2024Barclays PLC539,713$10.05M0.0%+3.4%0.537%Search for SEC Filing on Google Icon
2/15/2024Vanguard Group Inc.5,381,904$100.16M0.0%+1.8%5.356%Search for SEC Filing on Google Icon
2/15/2024Viking Global Investors LP5,145,112$95.75M0.4%+12.5%5.120%Search for SEC Filing on Google Icon
2/15/2024Weiss Multi Strategy Advisers LLC218,799$4.07M0.1%+2.2%0.218%Search for SEC Filing on Google Icon
2/15/2024Nuveen Asset Management LLC267,620$4.98M0.0%+1.3%0.266%Search for SEC Filing on Google Icon
2/15/2024Price T Rowe Associates Inc. MD55,236$1.03M0.0%+33.3%0.055%Search for SEC Filing on Google Icon
2/15/2024Profund Advisors LLC67,553$1.26M0.1%-28.1%0.067%Search for SEC Filing on Google Icon
2/14/2024Royal Bank of Canada70,766$1.32M0.0%+458.9%0.070%Search for SEC Filing on Google Icon
2/14/2024ADAR1 Capital Management LLC254,151$4.73M1.7%N/A0.253%Search for SEC Filing on Google Icon
2/14/2024Cubist Systematic Strategies LLC79,459$1.48M0.0%+679.0%0.079%Search for SEC Filing on Google Icon
2/14/2024Wasatch Advisors LP1,274,945$23.73M0.1%+32.4%1.269%Search for SEC Filing on Google Icon
2/14/2024Bellevue Group AG17,500$0.33M0.0%N/A0.017%Search for SEC Filing on Google Icon
2/14/2024Sei Investments Co.25,786$0.48M0.0%N/A0.026%Search for SEC Filing on Google Icon
2/13/2024Northern Trust Corp916,380$17.05M0.0%-1.2%0.912%Search for SEC Filing on Google Icon
2/13/2024Cetera Advisor Networks LLC23,248$0.43M0.0%+24.7%0.023%Search for SEC Filing on Google Icon
2/13/2024Oppenheimer & Co. Inc.30,857$0.57M0.0%+83.5%0.031%Search for SEC Filing on Google Icon
2/13/2024Tower Research Capital LLC TRC 18,891$0.35M0.0%+134.1%0.019%Search for SEC Filing on Google Icon
2/13/2024Affinity Asset Advisors LLC300,000$5.58M1.0%-1,020.2%0.299%Search for SEC Filing on Google Icon
2/13/2024Goldman Sachs Group Inc.1,119,885$20.84M0.0%+88.3%1.114%Search for SEC Filing on Google Icon
2/13/2024Rafferty Asset Management LLC413,278$7.69M0.0%-26.2%0.411%Search for SEC Filing on Google Icon
2/13/2024NEOS Investment Management LLC14,571$0.27M0.0%N/A0.014%Search for SEC Filing on Google Icon
2/13/2024The Manufacturers Life Insurance Company 47,073$0.88M0.0%-2.0%0.047%Search for SEC Filing on Google Icon
2/13/2024Campbell & CO Investment Adviser LLC29,278$0.55M0.0%N/A0.029%Search for SEC Filing on Google Icon
2/13/2024California State Teachers Retirement System91,571$1.70M0.0%-9.0%0.091%Search for SEC Filing on Google Icon
2/12/2024Eagle Asset Management Inc.261,783$4.87M0.0%N/A0.261%Search for SEC Filing on Google Icon
2/12/2024Dorsey & Whitney Trust CO LLC18,343$0.34M0.0%N/A0.018%Search for SEC Filing on Google Icon
2/12/2024Stifel Financial Corp10,237$0.19M0.0%N/A0.010%Search for SEC Filing on Google Icon
2/12/2024Steward Partners Investment Advisory LLC38,746$0.72M0.0%+121.4%0.039%Search for SEC Filing on Google Icon
2/9/2024US Bancorp DE2,346$44K0.0%+66.5%0.002%Search for SEC Filing on Google Icon
2/9/2024Nemes Rush Group LLC5,000$93K0.0%N/A0.005%Search for SEC Filing on Google Icon
2/9/2024Franklin Resources Inc.15,058$0.28M0.0%-68.5%0.015%Search for SEC Filing on Google Icon
2/9/2024Corient Private Wealth LLC21,472$0.40M0.0%N/A0.021%Search for SEC Filing on Google Icon
2/9/2024UBS Group AG339,726$6.32M0.0%+136.4%0.340%Search for SEC Filing on Google Icon
2/8/2024Level Four Advisory Services LLC31,374$0.58M0.0%+87.5%0.031%Search for SEC Filing on Google Icon
2/8/2024Massachusetts Financial Services Co. MA663,155$12.34M0.0%N/A0.663%Search for SEC Filing on Google Icon
2/7/2024Principal Financial Group Inc.11,114$0.21M0.0%+9.6%0.011%Search for SEC Filing on Google Icon
2/7/2024Dimensional Fund Advisors LP62,133$1.16M0.0%-85.4%0.062%Search for SEC Filing on Google Icon
2/7/2024Jump Financial LLC33,837$0.63M0.0%-81.5%0.034%Search for SEC Filing on Google Icon
2/7/2024BNP Paribas Financial Markets242,425$4.51M0.0%-35.9%0.242%Search for SEC Filing on Google Icon
2/7/2024Teacher Retirement System of Texas19,916$0.37M0.0%-23.1%0.020%Search for SEC Filing on Google Icon
2/7/2024E Fund Management Co. Ltd.22,195$0.41M0.0%-22.9%0.022%Search for SEC Filing on Google Icon
2/6/2024Charles Schwab Investment Management Inc.775,699$14.44M0.0%+1.4%0.775%Search for SEC Filing on Google Icon
2/6/2024Lisanti Capital Growth LLC348,970$6.49M1.5%N/A0.349%Search for SEC Filing on Google Icon
2/6/2024Amalgamated Bank13,613$0.25M0.0%-6.6%0.014%Search for SEC Filing on Google Icon
2/6/2024Swiss National Bank167,600$3.12M0.0%-15.1%0.168%Search for SEC Filing on Google Icon
2/6/2024JFG Wealth Management LLC12,000$0.22M0.1%N/A0.012%Search for SEC Filing on Google Icon
2/5/2024Victory Capital Management Inc.37,500$0.70M0.0%+8.9%0.037%Search for SEC Filing on Google Icon
2/5/2024Russell Investments Group Ltd.256,633$4.78M0.0%N/A0.257%Search for SEC Filing on Google Icon
2/1/2024New York State Common Retirement Fund39,321$0.73M0.0%+1.6%0.039%Search for SEC Filing on Google Icon
2/1/2024Handelsbanken Fonder AB22,700$0.42M0.0%+47.4%0.023%Search for SEC Filing on Google Icon
1/31/2024Wetzel Investment Advisors Inc.2,000$37K0.0%N/A0.002%Search for SEC Filing on Google Icon
1/31/2024Knights of Columbus Asset Advisors LLC81,687$1.52M0.1%+101.4%0.082%Search for SEC Filing on Google Icon
1/30/2024Zurcher Kantonalbank Zurich Cantonalbank 20,337$0.38M0.0%+22.2%0.020%Search for SEC Filing on Google Icon
1/25/2024International Assets Investment Management LLC19,968$0.37M0.0%-10.9%0.020%Search for SEC Filing on Google Icon
1/25/2024180 Wealth Advisors LLC10,000$0.18M0.0%-23.1%0.010%Search for SEC Filing on Google Icon
1/24/2024International Assets Investment Management LLC371,604$6.92M0.0%+1,557.6%0.371%Search for SEC Filing on Google Icon
1/24/2024Arizona State Retirement System23,768$0.44M0.0%-7.1%0.024%Search for SEC Filing on Google Icon
1/22/2024Pallas Capital Advisors LLC14,366$0.27M0.0%+6.8%0.014%Search for SEC Filing on Google Icon
1/16/2024Raymond James Financial Services Advisors Inc.147,452$2.74M0.0%+9.7%0.147%Search for SEC Filing on Google Icon
1/16/2024Raymond James & Associates137,583$2.56M0.0%+100.4%0.138%Search for SEC Filing on Google Icon
1/16/2024Salem Investment Counselors Inc.66,530$1.24M0.0%N/A0.067%Search for SEC Filing on Google Icon
1/16/2024Profit Investment Management LLC186,922$3.48M2.0%N/A0.187%Search for SEC Filing on Google Icon
1/16/2024Legato Capital Management LLC32,855$0.61M0.1%N/A0.033%Search for SEC Filing on Google Icon
1/12/2024SG Americas Securities LLC31,493$0.59M0.0%-61.6%0.031%Search for SEC Filing on Google Icon
12/18/2023Vanguard Group Inc.5,284,352$58.50M0.0%+3.4%5.283%Search for SEC Filing on Google Icon
12/7/2023Hudson Bay Capital Management LP214,339$2.37M0.0%N/A0.214%Search for SEC Filing on Google Icon
12/6/2023Citigroup Inc.359,585$3.98M0.0%+73.1%0.359%Search for SEC Filing on Google Icon
11/30/2023American Century Companies Inc.2,202,228$24.38M0.0%+59.6%2.202%Search for SEC Filing on Google Icon
11/24/2023Deutsche Bank AG318,288$3.52M0.0%+13.4%0.318%Search for SEC Filing on Google Icon
11/15/2023The Manufacturers Life Insurance Company 48,045$0.53M0.0%+29.9%0.048%Search for SEC Filing on Google Icon
11/15/2023GSA Capital Partners LLP89,741$0.99M0.1%+48.5%0.090%Search for SEC Filing on Google Icon
11/15/2023RTW Investments LP259,400$2.87M0.1%-74.1%0.259%Search for SEC Filing on Google Icon
11/15/2023AQR Capital Management LLC55,663$0.62M0.0%+77.3%0.056%Search for SEC Filing on Google Icon
11/14/2023683 Capital Management LLC625,000$6.92M0.5%+7.8%0.625%Search for SEC Filing on Google Icon
11/14/2023MPM Bioimpact LLC325,000$3.60M1.0%N/A0.325%Search for SEC Filing on Google Icon
11/14/2023Schonfeld Strategic Advisors LLC53,900$0.60M0.0%+17.3%0.054%Search for SEC Filing on Google Icon
11/14/2023Corton Capital Inc.12,041$0.13M0.1%N/A0.012%Search for SEC Filing on Google Icon
11/14/2023Deerfield Management Company L.P. Series C1,279,000$14.16M0.3%+13.7%1.279%Search for SEC Filing on Google Icon
11/14/2023Teza Capital Management LLC20,927$0.23M0.0%N/A0.021%Search for SEC Filing on Google Icon
11/14/2023California State Teachers Retirement System100,624$1.11M0.0%-12.7%0.101%Search for SEC Filing on Google Icon
11/14/2023Tower Research Capital LLC TRC 8,071$89K0.0%+185.9%0.008%Search for SEC Filing on Google Icon
11/14/2023Trexquant Investment LP84,147$0.93M0.0%-68.4%0.084%Search for SEC Filing on Google Icon
11/14/2023Profund Advisors LLC94,018$1.04M0.1%+50.0%0.094%Search for SEC Filing on Google Icon
11/13/2023Connor Clark & Lunn Investment Management Ltd.76,360$0.85M0.0%-61.3%0.076%Search for SEC Filing on Google Icon
11/13/2023Northern Trust Corp927,562$10.27M0.0%+1.7%0.927%Search for SEC Filing on Google Icon
11/13/2023Healthcare of Ontario Pension Plan Trust Fund310,000$3.43M0.0%N/A0.310%Search for SEC Filing on Google Icon
11/13/2023Aigen Investment Management LP13,396$0.15M0.0%N/A0.013%Search for SEC Filing on Google Icon
11/13/2023Invesco Ltd.864,589$9.57M0.0%+4.7%0.864%Search for SEC Filing on Google Icon
11/13/2023FMR LLC15,004,324$166.10M0.0%+0.2%15.000%Search for SEC Filing on Google Icon
11/13/2023Rafferty Asset Management LLC560,180$6.20M0.0%+63.6%0.560%Search for SEC Filing on Google Icon
11/13/2023Kestra Advisory Services LLC10,825$0.12M0.0%-41.5%0.011%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Viking Therapeutics logo
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; VK2735, a novel dual agonist of the glucagon-like peptide, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.
Read More on Viking Therapeutics

Today's Range

Now: $81.87
Low: $80.50
High: $84.70

50 Day Range

MA: $48.96
Low: $20.94
High: $94.50

52 Week Range

Now: $81.87
Low: $8.28
High: $99.41

Volume

3,029,084 shs

Average Volume

6,542,868 shs

Market Capitalization

$8.23 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.06

Who are the company insiders with the largest holdings of Viking Therapeutics?

Viking Therapeutics' top insider shareholders include:
  1. Brian Lian (CEO)
  2. Marianna Mancini (COO)
  3. Greg Zante (CFO)
  4. Lawson Macartney (Director)
  5. Charles A Rowland Jr (Director)
  6. Sarah Kathryn Rouan (Director)
Learn More about top insider investors at Viking Therapeutics.

Who are the major institutional investors of Viking Therapeutics?

Viking Therapeutics' top institutional investors include:
  1. Vanguard Group Inc. — 5.36%
  2. Vanguard Group Inc. — 5.36%
  3. Viking Global Investors LP — 5.12%
  4. Wasatch Advisors LP — 1.27%
  5. Goldman Sachs Group Inc. — 1.11%
  6. Goldman Sachs Group Inc. — 1.11%
Learn More about top institutional investors of Viking Therapeutics stock.

Which major investors are selling Viking Therapeutics stock?

In the previous quarter, VKTX stock was sold by these institutional investors:
  1. Dimensional Fund Advisors LP
  2. Jump Financial LLC
  3. Rafferty Asset Management LLC
  4. BNP Paribas Financial Markets
  5. SG Americas Securities LLC
  6. Franklin Resources Inc.
  7. Swiss National Bank
  8. Profund Advisors LLC
Within the last year, company insiders that have sold Viking Therapeutics company stock include:
  1. Brian Lian (CEO)
  2. Marianna Mancini (COO)
  3. Greg Zante (CFO)
  4. Lawson Macartney (Director)
  5. Charles A Rowland Jr (Director)
  6. Sarah Kathryn Rouan (Director)
Learn More investors selling Viking Therapeutics stock.

Which major investors are buying Viking Therapeutics stock?

Within the previous quarter, VKTX stock was purchased by institutional investors including:
  1. Massachusetts Financial Services Co. MA
  2. Viking Global Investors LP
  3. Goldman Sachs Group Inc.
  4. Goldman Sachs Group Inc.
  5. International Assets Investment Management LLC
  6. Lisanti Capital Growth LLC
  7. Affinity Asset Advisors LLC
  8. Wasatch Advisors LP